Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Kasahara · SciRah

Researcher profile · Semantic Scholar

S. Kasahara

Share profile

S. Kasahara — researcher profile on SciRah

h-index: 26
Works: 178
Citations: 2,826

Most-cited papers

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E. Bernard, Y. Nannya, R. Hasserjian, S. Devlin +76 more
2019Nature Medicine574 citations Open access
Semantic Scholar
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
E. Bernard, H. Tuechler, P. Greenberg, R. Hasserjian +60 more
2022NEJM Evidence251 citations
Semantic Scholar
Germline DDX41 mutations define a unique subtype of myeloid neoplasms.
H. Makishima, R. Saiki, Y. Nannya, S. Korotev +47 more
2022Blood140 citations Open access
Semantic Scholar
Endoscopic Ultrasound-Guided Fine Needle Aspiration Biopsy for Diagnosis of Lymphoproliferative Disorders: Feasibility of Immunohistological, Flow Cytometric, and Cytogenetic Assessments
I. Yasuda, N. Goto, H. Tsurumi, M. Nakashima +9 more
2012American Journal of Gastroenterology99 citations
Semantic Scholar
Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens
N. Goto, H. Tsurumi, Hideko Goto, Yoriko Shimomura +11 more
2012Annals of Hematology61 citations
Semantic Scholar
CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma
A. Okamoto, H. Fujigaki, Chisako Iriyama, N. Goto +19 more
2022Blood Advances39 citations Open access
Semantic Scholar
Postazacitidine clone size predicts long-term outcome of patients with myelodysplastic syndromes and related myeloid neoplasms
Y. Nannya, M. Tobiasson, Shinya Sato, E. Bernard +34 more
2023Blood Advances32 citations Open access
Semantic Scholar
R‐THP‐COP versus R‐CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open‐label, noninferiority phase 3 trial
T. Hara, T. Yoshikawa, Hideko Goto, M. Sawada +20 more
2018Hematological Oncology32 citations
Semantic Scholar
Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
H. Hayashi, R. Kobayashi, A. Suzuki, M. Ishihara +9 more
2014Anticancer Research28 citations
Semantic Scholar
TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes
E. Bernard, Y. Nannya, T. Yoshizato, R. Hasserjian +71 more
2019Blood21 citations Open access
Semantic Scholar
Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B‐cell lymphoma treated with the R‐CHOP regimen
Nobuhiko Nakamura, N. Goto, H. Tsurumi, M. Takemura +10 more
2013European Journal of Haematology18 citations
Semantic Scholar
CHOP or THP‐COP regimens in the treatment of newly diagnosed peripheral T‐cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin
Y. Shibata, T. Hara, S. Kasahara, Toshiki Yamada +15 more
2017Hematological Oncology16 citations
Semantic Scholar
Author Correction: Magnitude, demographics and dynamics of the effect of the first wave of the COVID-19 pandemic on all-cause mortality in 21 industrialized countries
E. Bernard, Y. Nannya, R. Hasserjian, S. Devlin +76 more
2021Nature Medicine15 citations Open access
Semantic Scholar
Prognostic impact of the controlling nutritional status score in patients with peripheral T-cell lymphoma
Nobuhiko Nakamura, N. Kanemura, Shin Lee, K. Fujita +11 more
2021Leukemia and Lymphoma14 citations Open access
Semantic Scholar
Risk factors for developing infusion reaction after rituximab administration in patients with B-cell non-Hodgkin's lymphoma.
T. Tachi, M. Yasuda, Kazumasa Usui, M. Umeda +9 more
2015Pharmazie14 citations Open access
Semantic Scholar
Low-dose anti-thymocyte globulin for GVHD prophylaxis in HLA-matched allogeneic peripheral blood stem cell transplantation
S. Shiratori, Junichi Sugita, S. Ota, S. Kasahara +10 more
2020Bone Marrow Transplantation13 citations
Semantic Scholar
Impact of myelodysplasia-related gene mutations and residual mutations at remission in venetoclax/azacitidine for AML
Yoshikazu Ikoma, N. Nakamura, Yuto Kaneda, Hiroyuki Takamori +30 more
2025Leukemia12 citations Open access
Semantic Scholar
Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial
J. Kitagawa, R. Kobayashi, Yasuyuki Nagata, S. Kasahara +9 more
2020International Journal of Cancer12 citations Open access
Semantic Scholar
Elevation of serum interleukins 8, 4, and 1β levels in patients with gastrointestinal low-grade B-cell lymphoma
T. Miyata-Takata, K. Takata, T. Toji, N. Goto +7 more
2015Scientific Reports12 citations Open access
Semantic Scholar
Low dose palliative radiotherapy for refractory aggressive lymphoma.
O. Tanaka, M. Oguchi, T. Iida, S. Kasahara +2 more
2016Reports of Practical Oncology & Radiotherapy11 citations Open access
Semantic Scholar
Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
N. Sekiguchi, S. Kasahara, T. Miyamoto, T. Kiguchi +7 more
2022International journal of hematology10 citations Open access
Semantic Scholar
NUP98 rearrangements in adult AML patients: evaluation of clinical implications and identification of novel fusion partners
K. Chonabayashi, M. Iwasaki, J. Kanda, Hiroyuki Takamori +28 more
2026Leukemia9 citations Open access
Semantic Scholar
DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study
C. Gurnari, Hideki Makishima, Arda Durmaz, E. Attardi +29 more
2025Leukemia9 citations
Semantic Scholar
Clinical Impacts of Germline DDX41 Mutations on Myeloid Neoplasms
H. Makishima, Y. Nannya, J. Takeda, Y. Momozawa +37 more
20209 citations
Semantic Scholar
Immunoreactivity to WT1 peptide vaccine is associated with prognosis in elderly patients with acute myeloid leukemia: follow-up study of randomized phase II trial of OCV-501, an HLA class II-binding WT1 polypeptide
T. Naoe, A. Saito, Nahoko Hosono, S. Kasahara +15 more
2023Cancer Immunology and Immunotherapy8 citations Open access
Semantic Scholar
Significant correlation between the acceleration of platelet aggregation and phosphorylation of HSP27 at Ser-78 in diabetic patients.
H. Tokuda, Kenji Kato, S. Kasahara, R. Matsushima-Nishiwaki +3 more
2012International Journal of Molecular Medicine8 citations Open access
Semantic Scholar
A salvage chemotherapy of R‐P‐IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R‐CHOP therapy as first‐line chemotherapy
Takuro Matsumoto, T. Hara, Y. Shibata, Nobuhiko Nakamura +14 more
2017Hematological Oncology7 citations
Semantic Scholar
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemia
Y. Ochi, Markus Liew-Littorin, Y. Nannya, S. Bengtzén +47 more
2026Nature6 citations Open access
Semantic Scholar
Polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) therapy in diffuse large B-cell lymphoma in patients aged 80 years or older: a real-world study
Toshiki Yamada, N. Nakamura, Hideko Goto, Takeshi Hara +12 more
2025Annals of Hematology6 citations Open access
Semantic Scholar
Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy.
Kotaro Miyao, S. Terakura, Yukiyasu Ozawa, M. Sawa +12 more
2021Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
Graft-versus-host disease prophylaxis using low-dose antithymocyte globulin in peripheral blood stem cell transplantation - A matched-pair analysis.
S. Shiratori, Mio Kurata, J. Sugita, S. Ota +11 more
2021Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia
Hirofumi Yokota, Kotaro Miyao, M. Sawa, S. Terakura +20 more
2024Journal of Hematology4 citations Open access
Semantic Scholar
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma
Yuto Kaneda, N. Kanemura, Nobuhiko Nakamura, Yoshikazu Ikoma +13 more
2023Leukemia and Lymphoma4 citations
Semantic Scholar
Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population
Nobuhiko Nakamura, N. Kanemura, Takuro Matsumoto, Hiroshi Nakamura +16 more
2023Scientific Reports4 citations Open access
Semantic Scholar
Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
E. Bernard, Y. Nannya, R. Hasserjian, S. Devlin +75 more
2021Nature Medicine4 citations Open access
Semantic Scholar
Burkitt lymphoma presenting rapid progression from unilateral to bilateral cavernous sinus syndrome as the initial symptom
Yuji Tanaka, Y. Takagi, S. Kasahara, Hideko Goto +3 more
20144 citations Open access
Semantic Scholar
[Analysis of factors influencing the occurrence of infusion reaction after initial treatment with rituximab].
M. Yasuda, T. Tachi, M. Umeda, Kazumasa Usui +8 more
2014Gan to kagaku ryoho. Cancer & chemotherapy4 citations
Semantic Scholar
Zanubrutinib in Japanese treatment-naive and relapsed/refractory patients with Waldenström macroglobulinemia and CLL/SLL
K. Izutsu, Takayuki Ishikawa, K. Shimada, Kohmei Kubo +14 more
2025International journal of hematology3 citations Open access
Semantic Scholar
Genetic analysis of myeloid neoplasms with der(1;7)(q10;p10)
R. Okuda, Y. Ochi, R. Saiki, Toshiyuki Yamanaka +36 more
2024Leukemia3 citations Open access
Semantic Scholar
Comparison of 19-gauge conventional and Franseen needles for the diagnosis of lymphadenopathy and classification of malignant lymphoma using endoscopic ultrasound fine-needle aspiration
M. Okuno, Keisuke Iwata, Tsuyoshi Mukai, Yusuke Kito +11 more
2023Clinical Endoscopy3 citations Open access
Semantic Scholar
A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non‐Hodgkin lymphoma
Yoshikazu Ikoma, Nobuhiko Nakamura, J. Kitagawa, Takao Miwa +10 more
2023Hematological Oncology3 citations
Semantic Scholar
Efficacy and Safety of Zanubrutinib in Japanese Patients with Mature B-Cell Malignancies
T. Ishikawa, M. Takeuchi, K. Shimada, Kohmei Kubo +18 more
2022Blood3 citations Open access
Semantic Scholar
Der(1;7)(q10;p10) Presents with a Unique Genetic Profile and Frequent ETNK1 Mutations in Myeloid Neoplasms
R. Okuda, Y. Nannya, Y. Ochi, M. Creignou +21 more
2021Blood3 citations
Semantic Scholar
Distinct, Ethnic, Clinical, and Genetic Characteristics of Myelodysplastic Syndromes with Der(1;7)
R. Okuda, H. Makishima, Y. Nannya, Y. Ochi +18 more
2019Blood3 citations Open access
Semantic Scholar
Gemcitabine, Carboplatin, Dexamethasone, and Rituximab Versus High‐Dose Cytarabine‐Based Chemotherapy as Second‐Line Treatments for Relapsed or Refractory Diffuse Large B‐Cell Lymphoma
Yoshikazu Ikoma, N. Nakamura, J. Kitagawa, Naoki Hayase +15 more
2025Hematological Oncology2 citations Open access
Semantic Scholar
Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine
Eri Takada, Nobuhiko Nakamura, Yuto Kaneda, K. Fukuno +12 more
2024Hematology Reports2 citations Open access
Semantic Scholar
Molecular Landscape of Myeloid Neoplasms with Der(1;7)(q10;p10)
R. Okuda, Y. Ochi, K. Chonabayashi, N. Hiramoto +28 more
2022Blood2 citations Open access
Semantic Scholar
A multicenter phase II study of bendamustine, rituximab, and cytarabine (BRAC) for relapsed or refractory patients with follicular lymphoma or mantle cell lymphoma
Nobuhiko Nakamura, S. Kasahara, J. Kitagawa, Hiroshi Nakamura +8 more
2022Experimental Hematology & Oncology2 citations Open access
Semantic Scholar
Efficacy and safety of modified BLd therapy for Japanese patients with transplant-ineligible multiple myeloma
Satsuki Murakami, Masaki Ri, Masato Ito, Nobuhiko Nakamura +17 more
2022International journal of hematology2 citations
Semantic Scholar
[Thrombotic thrombocytopenic purpura during pregnancy refractory to plasma exchange and rituximab].
Yuto Kaneda, J. Kitagawa, Kimihiro Yamaguchi, Takuro Matsumoto +8 more
2019[Rinsho ketsueki] The Japanese journal of clinical hematology2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

H. Tsurumi×22
Invite
H. Tsurumi — researcher profile on SciRah
N. Kanemura×21
Invite
N. Kanemura — researcher profile on SciRah
Y. Nannya×17
Invite
Y. Nannya — researcher profile on SciRah
Nobuhiko Nakamura×14
Invite
Nobuhiko Nakamura — researcher profile on SciRah

×13

Invite

Y. Atsuta — researcher profile on SciRah

J. Kitagawa×13

Invite

J. Kitagawa — researcher profile on SciRah

A. Takaori-Kondo×11

Invite

A. Takaori-Kondo — researcher profile on SciRah

Invite

Y. Shibata — researcher profile on SciRah

Invite

M. Sawada — researcher profile on SciRah

Hiroshi Nakamura×11

Invite

Hiroshi Nakamura — researcher profile on SciRah

Invite

R. Saiki — researcher profile on SciRah

M. Creignou×10

Invite

M. Creignou — researcher profile on SciRah